Lilly unveils $3.5B factory that will make retatrutide and other obesity drugs

Eli Lilly has budgeted $3.5 billion for a new weight loss injectable and device factory in Lehigh Valley, PA, which will manufacture its next-gen obesity drug retatrutide. The factory will also produce other weight loss ...